|
Contents
|
|
|
|
Glioblastoma
|
 
|
|
|
|
Das
P, Puri T, Jha P, Pathak P, Joshi N, Suri V, Sharma MC, Sharma BS, Mahapatra
AK, Suri A, Sarkar C.
A clinicopathological and molecular analysis of glioblastoma multiforme with
long-term survival.
J Clin Neurosci. 2010 Sep 29;. [Epub ahead of print]
.JPG)
Abstract |
.gif) Related articles
|
|
|
Marko NF, Toms SA, Barnett GH, Weil R.
Genomic expression patterns distinguish long-term from short-term
glioblastoma survivors: A preliminary feasibility study
Genomics. 2008 Mar 17; [Epub ahead of print]
Abstract
|
|
|
Sonoda Y, Kumabe T, Watanabe M, Nakazato Y,
Inoue T, Kanamori M, Tominaga T
Long-term survivors of glioblastoma: clinical features and molecular
analysis
Acta Neurochir (Wien). 2009 May 12;. [Epub ahead of print]
Abstract
|
|
|
Yang
I, Tihan T, Han SJ, Wrensch MR, Wiencke J, Sughrue ME, Parsa AT
CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with
long-term survival
J Clin Neurosci. 2010 Aug 18;. [Epub ahead of print]
Abstract
|
|
|
Medulloblastoma |
|
|
|
|
Pfaff
E, Remke M, Sturm D, Benner A, Witt H, Milde T, von Bueren AO, Wittmann A,
Schöttler A, Jorch N, Graf N, Kulozik AE, Witt O, Scheurlen W, von Deimling
A, Rutkowski S, Taylor MD, Tabori U, Lichter P, Korshunov A, Pfister SM.
TP53
Mutation Is Frequently Associated With CTNNB1 Mutation or MYCN Amplification
and Is Compatible With Long-Term Survival in Medulloblastoma.
J
Clin Oncol. 2010 Nov 8. [Epub ahead of print]
Abstract |
Related articles
|
|
